A Hypothesis of the Origin of Human Breast Cancer from the Terminal Ductal Lobular Unit1

https://doi.org/10.1016/S0344-0338(80)80248-2Get rights and content

Summary

The data reported and reviewed herein supports the hypothesis that most human mammary carcinomas, including the common scirrhous (infiltrating duct) type, arise in the terminal ductal lobular unit. The evidence is based on a study of the total pathology of 290 whole human breasts utilizing a three-dimensional subgross sampling technique with histological correlation. One hundred and eighty-three of the breasts were from random autopsies, and 107 were from patients who had mammary carcinoma. A total of over 16,000 lesions were observed in the 290 breasts. Almost all lesions observed, including epithelial cysts, apocrine metaplasia, sclerosing adenosis, fibroadenomas, atypical lobules (AL), atypical terminal ductal hyperplasia, papillomas of terminal ducts, ductal carcinoma-in-situ, and lobular carcinoma-in-situ are localized to the terminal ductal lobular unit (TDLU). Exceptions to this include: intraductal papillomas and rare instances of hyperplasia of the epithelium of ducts larger than terminal ducts. Lesions of all kinds are generally much more frequent in cancer-containing breasts, or in breasts contralateral to cancer, than in random-autopsy breasts. One very common lesion of the terminal ductal lobular unit, named “atypical lobule, type A”, or ALA, is of particular importance as the only lesion of the many observed than can be graded and arranged into an arbitrary series of increasing atypia, linking normal lobular structure to carcinoma-in-situ of the ductal type (DCIS). We conclude that most human mammary epithelial lesions, including those of mammary dysplasia (fibrocystic disease), and presumptively precancerous atypical epithelial proliferations, arise in the terminal ductal lobular units.

References (12)

  • A.M. Cameron et al.

    Hyperplastic and inflammatory nodules in the canine mammary gland

    J. Nat. Cancer Inst.

    (1971)
  • A.M. Cameron

    Subgross evaluation of the nonhuman primate mammary glands. Methods and initial observations

    J. Med. Primatol.

    (1974)
  • K.B. DeOme et al.

    Development of mammary tumors from hyperplastic alveolar nodules transplanted into the gland-free mammary fat pads of female C3H mice

    Cancer Res.

    (1959)
  • H.B. DeOme et al.

    Some characteristics of the preneoplastic hyperplastic alveolar nodules of the C3H/Crgl mice

    Acta Union Internat. Contra Cancrum

    (1961)
  • H.M. Jensen et al.

    Preneoplastic lesions of the human mammary gland

    Science

    (1976)
  • H.M. Jensen et al.

    Preneoplastic lesions of the human mammary gland transplanted into the nude athymic mouse

    Cancer Res.

    (1976)
There are more references available in the full text version of this article.

Cited by (83)

  • Ultrasound Image Classification of Ductal Carcinoma In Situ (DCIS) of the Breast: Analysis of 705 DCIS Lesions

    2017, Ultrasound in Medicine and Biology
    Citation Excerpt :

    In that regard, the histopathology of DCIS is useful for understanding these variations. Ductal carcinoma in situ is considered to develop primarily at a terminal duct lobular unit (TDLU) (Wellings 1980) and then to extend within the mammary ductal lobular system. This system consists of the TDLU, subsegmental duct, segmental duct, lactiferous sinus and collecting duct (Allred 2010; Ohuchi et al. 1984; Wellings et al. 1975).

  • Extranodal Lymphoma of the Breast

    2016, Radiologic Clinics of North America
    Citation Excerpt :

    There are 15 to 20 segments or lobes in the developed breast with each draining at the lactiferous duct into the nipple. Fig. 3 shows the lobule, the functional unit of the breast, which is made up of the terminal ducts, and acini.23 The lobules change significantly during the menstrual cycles and after menopause they atrophy and decrease in number.

View all citing articles on Scopus
1

This work was supported by grant nos. 1ROI CA 21523-01 and 1ROI CA 21366-01 from the National Cancer Institute, Department of Helath, Education, and Welfare.

1

Sefton R. Wellings, M. D., Ph. D., Department of Pathology, School of Medicine, University of California, Davis, California 95616, U.S.A.

View full text